NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Coller Capital’

7 February 2014

Gene therapy company uniQure raises over $80m via IPO

biotech_lrg Venture capital-backed gene therapy specialist uniQure has raised nearly $82m via an IPO on the Nasdaq exchange, which was priced above the indicative range.

22 January 2014

Pension funds lagging sophisticated investors with private equity exposurep

Pension funds remain underweight in private equity compared to the allocations of family offices/endowments and sovereign wealth funds, according to new research.

3 January 2014

Gene therapy company uniQure plans $75m Nasdaq IPO

stocks2_lrg Venture capital-backed gene therapy specialist uniQure plans to raise $75m via an IPO on the Nasdaq exchange, according to a filing with US securities regulators.

9 December 2013

LPs set to grow private equity allocation, investment teamsp

Private equity has become more attractive as an asset class in the wake of the global financial crisis, with over a third of investors planning to increase their target allocation and many of the world’s largest investors are planning to grow the size of their private equity teams.

5 December 2013

Coller Capital given go-ahead to buy Credit Suisse mid-market buyout arm stake

cheque_deal_pen_170sq Secondary private equity investment giant Coller Capital has reportedly picked up Credit Suisse's stake in its mid-market buyout arm, DLJ Merchant Banking.

20 November 2013

JPMorgan Chase eyes $4bn secondaries sale

Banking and financial services group JPMorgan Chase & Co is looking to sell close to $4bn of private equity LP stakes to investors including CPPIB, Coller Capital, Goldman Sachs, Lexington Capital, HarbourVest and Ardian

2 October 2013

Omnes continues post spin-out investment spree with €3m Opsona backing

Opsona research lab Omnes Capital has continued its investment spree since splitting from temporary owner Coller Capital in January by investing €3m in immune drug development company Opsona Therapeutics.

16 July 2013

Omnes Capital backs Eratome group LBO with €15m

Omnes Capital, the former private equity arm of Crédit Agricole, has invested €15m in the leveraged buyout of social housing renovation specialist Eratome group.

11 June 2013

LP confidence in private equity remains strong despite concernsp

While LPs believe the core elements of private equity’s model have proved themselves, there are a number of areas where investors expressed caution.

10 June 2013

Private equity needs to justify its performance “again and again”p

While many investors are eager to reaffirm their support for private equity following the financial crisis, there is still much to be done to ensure the asset class maintains LP support and capital flows, according to Coller Capital’s latest Barometer.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014